503 related articles for article (PubMed ID: 22246828)
21. Lack of association of hepatitis C virus load and genotype with risk of end-stage liver disease in patients with human immunodeficiency virus coinfection.
Goedert JJ; Hatzakis A; Sherman KE; Eyster ME;
J Infect Dis; 2001 Nov; 184(9):1202-5. PubMed ID: 11598846
[TBL] [Abstract][Full Text] [Related]
22. Role of hepatitis C virus (HCV) viremia and HCV genotype in the immune recovery from highly active antiretroviral therapy in a cohort of antiretroviral-naive HIV-infected individuals.
Antonucci G; Girardi E; Cozzi-Lepri A; Capobianchi MR; De Luca A; Puoti M; Petrelli E; Carnevale G; Rizzardini G; Grossi PA; Viganò P; Moioli MC; Carletti F; Solmone M; Ippolito G; Monforte AD; ;
Clin Infect Dis; 2005 Jun; 40(12):e101-9. PubMed ID: 15909251
[TBL] [Abstract][Full Text] [Related]
23. RNA-HCV viral load in serum, peripheral blood mononuclear cells and liver in children with chronic hepatitis C.
Kowala-Piaskowska A; Mozer-Lisewska I; Januszkiewicz-Lewandowska D; Michalak M; Zeromski J; Madaliński K; Słuzewski W
Acta Pol Pharm; 2012; 69(5):859-63. PubMed ID: 23061281
[TBL] [Abstract][Full Text] [Related]
24. Real-time multiplex PCR assay to quantify hepatitis C virus RNA in peripheral blood mononuclear cells.
Pugnale P; Latorre P; Rossi C; Crovatto K; Pazienza V; Gottardi AD; Negro F
J Virol Methods; 2006 May; 133(2):195-204. PubMed ID: 16384611
[TBL] [Abstract][Full Text] [Related]
25. HCV kinetics, quasispecies, and clearance in treated HCV-infected and HCV/HIV-1-coinfected patients with hemophilia.
Shire NJ; Horn PS; Rouster SD; Stanford S; Eyster ME; Sherman KE;
Hepatology; 2006 Nov; 44(5):1146-57. PubMed ID: 17058240
[TBL] [Abstract][Full Text] [Related]
26. The correlation between hepatitis C core antigen and hepatitis C virus RNA levels with respect to human immunodeficiency virus status, hepatitis C virus genotype and interferon-lambda-4 polymorphism.
Thong VD; Akkarathamrongsin S; Avihingsanon A; Theamboonlers A; Poovorawan Y; Tangkijvanich P
Intervirology; 2015; 58(2):73-9. PubMed ID: 25677196
[TBL] [Abstract][Full Text] [Related]
27. Analytical and clinical sensitivity of the Procleix Ultrio HIV-1/HCV/HBV assay in samples with a low viral load.
Katsoulidou A; Moschidis Z; Sypsa V; Chini M; Papatheodoridis GV; Tassopoulos NC; Mimidis K; Karafoulidou A; Hatzakis A
Vox Sang; 2007 Jan; 92(1):8-14. PubMed ID: 17181585
[TBL] [Abstract][Full Text] [Related]
28. Increased hepatitis C viral load and reactivation of liver disease in HCV RNA-positive patients with onco-haematological disease undergoing chemotherapy.
Coppola N; Pisaturo M; Guastafierro S; Tonziello G; Sica A; Iodice V; Sagnelli C; Ferrara MG; Sagnelli E
Dig Liver Dis; 2012 Jan; 44(1):49-54. PubMed ID: 21885355
[TBL] [Abstract][Full Text] [Related]
29. Presence of different hepatitis C virus genotypes in plasma and peripheral blood mononuclear cell samples of Iranian patients with HIV infection.
Dehghani-Dehej F; Sarvari J; Esghaei M; Hosseini SY; Garshasbi S; Kalantari S; Monavari SH; Fakhim A; Keyvani H; Bokharaei-Salim F
J Med Virol; 2018 Aug; 90(8):1343-1351. PubMed ID: 28845894
[TBL] [Abstract][Full Text] [Related]
30. HCV viraemia associates with NK cell activation and dysfunction in antiretroviral therapy-treated HIV/HCV-co-infected subjects.
Papasavvas E; Azzoni L; Yin X; Liu Q; Joseph J; Mackiewicz A; Ross B; Lynn KM; Jacobson JM; Mounzer K; Kostman JR; Montaner LJ
J Viral Hepat; 2017 Oct; 24(10):865-876. PubMed ID: 28419653
[TBL] [Abstract][Full Text] [Related]
31. Liver injury and changes in hepatitis C Virus (HCV) RNA load associated with protease inhibitor-based antiretroviral therapy for treatment-naive HCV-HIV-coinfected patients: lopinavir-ritonavir versus nelfinavir.
Sherman KE; Shire NJ; Cernohous P; Rouster SD; Omachi JH; Brun S; Da Silva B
Clin Infect Dis; 2005 Oct; 41(8):1186-95. PubMed ID: 16163639
[TBL] [Abstract][Full Text] [Related]
32. Hepatitis G viral RNA in serum and in peripheral blood mononuclear cells and its relation to HCV-RNA in patients with clotting disorders.
Sheng L; Soumillion A; Peerlinck K; Verslype C; Lin L; van Pelt J; Hess G; Vermylen J; Yap SH
Thromb Haemost; 1997 May; 77(5):868-72. PubMed ID: 9184394
[TBL] [Abstract][Full Text] [Related]
33. Complete eradication of hepatitis C virus after interferon treatment for chronic hepatitis C.
De Mitri MS; Morsica G; Chen CH; Mele L; Baccarini P; Chianese R; Piccinini A; Lazzarin A; Pisi E
Ital J Gastroenterol Hepatol; 1997 Jun; 29(3):255-61. PubMed ID: 9646218
[TBL] [Abstract][Full Text] [Related]
34. Dissociation of serum and liver hepatitis C virus RNA levels in patients coinfected with human immunodeficiency virus and treated with antiretroviral drugs.
Furione M; Maserati R; Gatti M; Baldanti F; Cividini A; Bruno R; Gerna G; Mondelli MU
J Clin Microbiol; 2004 Jul; 42(7):3012-6. PubMed ID: 15243052
[TBL] [Abstract][Full Text] [Related]
35. Treatment of hepatitis C virus infection with human ezrin peptide one (HEP1) in HIV infected patients.
Salamov G; Holms R; Bessler WG; Ataullakhanov R
Arzneimittelforschung; 2007; 57(7):497-504. PubMed ID: 17803064
[TBL] [Abstract][Full Text] [Related]
36. A potent antiviral effect on hepatitis C viral dynamics in serum and peripheral blood mononuclear cells during combination therapy with high-dose daily interferon alfa plus ribavirin and intravenous twice-daily treatment with interferon beta.
Asahina Y; Izumi N; Uchihara M; Noguchi O; Tsuchiya K; Hamano K; Kanazawa N; Itakura J; Miyake S; Sakai T
Hepatology; 2001 Aug; 34(2):377-84. PubMed ID: 11481623
[TBL] [Abstract][Full Text] [Related]
37. Predictive factors of virological non-response to interferon-ribavirin combination therapy for patients infected with hepatitis C virus of genotype 1b and high viral load.
Akuta N; Suzuki F; Sezaki H; Suzuki Y; Hosaka T; Someya T; Kobayashi M; Saitoh S; Watahiki S; Sato J; Kobayashi M; Arase Y; Ikeda K; Kumada H
J Med Virol; 2006 Jan; 78(1):83-90. PubMed ID: 16299715
[TBL] [Abstract][Full Text] [Related]
38. Increased hepatitis C virus load among injection drug users infected with human immunodeficiency virus and human T lymphotropic virus type II.
Hisada M; Chatterjee N; Zhang M; Battjes RJ; Goedert JJ
J Infect Dis; 2003 Sep; 188(6):891-7. PubMed ID: 12964121
[TBL] [Abstract][Full Text] [Related]
39. Effect of IL-2 on hepatitis C virus RNA levels in patients co-infected with human immunodeficiency virus receiving HAART.
Tedaldi EM; Chen L; Markowitz N; Kelly L; Abrams D;
J Viral Hepat; 2005 Jul; 12(4):414-20. PubMed ID: 15985013
[TBL] [Abstract][Full Text] [Related]
40. GB virus C (GBV-C) infection in hepatitis C virus (HCV)/HIV-coinfected patients receiving HCV treatment: importance of the GBV-C genotype.
Schwarze-Zander C; Blackard JT; Zheng H; Addo MM; Lin W; Robbins GK; Sherman KE; Zdunek D; Hess G; Chung RT;
J Infect Dis; 2006 Aug; 194(4):410-9. PubMed ID: 16845623
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
